2016ESC房颤治疗指南概要解读.ppt

对1084例真实世界里的房颤患者用不同危险分层方法进行评估 Abstract Background Contemporary clinical risk stratification schema for predicting stroke and thromboembolism(TE) in patients with atrial fibrillation(AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. Methods We refined the 2006 Birmingham/NICE stroke risk stratification schema into a risk factor based approach, by reclassifying and/or incorporating additional new risk factors, where relevant. This schema was then compared to existing stroke risk stratification schema in a ‘real world’ AF patient cohort(n=1084) from the EuroHeart Survey for AF. Results Risk categorization differed widely between the different schemes compared. Patients classified as ‘high risk’ ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The ‘classical’ CHADS2 categorised the largest proportion(61.9%) into the ‘intermediate risk’ strata, whilst the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as ‘low risk’, whilst the Framingham scheme categorized 48.3% as ‘low risk’. Calculated c-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (c-statistic 0.606) than CHADS2. However, those classified as ‘low risk’ by the Birmingham 2009 and NICE schema were truly ‘low risk’ with no TE events recorded, whilst TE events occurred in 1.4% of ‘low risk’ CHADS2 subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA2DS2-VASc acronym) showed an increase in TE rate with increasing scores (p value for trend=0.003). Conclusion Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS2 schema, with low event rates in ‘low risk’ subjects and the classification of only a small proportion of subjects into the ‘intermediate risk’